Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations-Reference-Cited by-同舟云学术

Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations

Published:2020-02 Issue:4 Volume:125 Page:491-499
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

D'Ascenzo Fabrizio^ORCID,Barbero Umberto,Abdirashid Mohamed^ORCID,Trabattoni Daniela,Boccuzzi Giacomo,Ryan Nicola^ORCID,Quadri Giorgio,Capodanno Davide,Venuti Giuseppe^ORCID,Muscoli Saverio,Tomassini Francesco,Autelli Michele,Montabone Andrea,Wojakowski Wojciech,Rognoni Andrea,Gallo Diego^ORCID,Parma Radoslaw,De Luca Leonardo^ORCID,Figini Filippo,Mitomo Satoru,Montefusco Antonio,Mattesini Alessio^ORCID,Wańha Wojciech,Protasiewicz Marcin,Smolka Grzegorz,Huczek Zenon,Rolfo Cristina,Cortese Bernardo^ORCID,Chieffo Alaide,Kuliczowki Wiktor,Nuñez-Gil Ivan,Morbiducci Umberto^ORCID,Ugo Fabrizio,Marengo Giorgio,Iannaccone Mario^ORCID,Cerrato Enrico,Mario Carlo di,Moretti Claudio,D'Amico Maurizio,Varbella Ferdinando,Lüscher Thomas F.,Sheiban Imad,Escaned Javier,Romeo Francesco,Rinaldi Mauro,De Ferrari Gaetano Maria,Helft Gerard

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;N Engl J Med,2014

2. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54;Bonaca;Eur Heart J,2016

3. Meta-analysis of the duration of dual antiplatelet therapy in patients treated with second-generation drug-eluting stents;D'Ascenzo;Am J Cardiol,2016

4. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal safety and efficacy of 3-month dual antiplatelet Therapy following endeavor zotarolimus-eluting stent implantation);Kim;J Am Coll Cardiol,2012

5. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the efficacy of xience/promus versus cypher to reduce late loss after stenting (EXCELLENT) randomized, multicenter study;Gwon;Circulation,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Less Is More: Developments in Nanotechnology for Antirestenosis Therapies;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-07

2. Tratamiento antiagregante plaquetario doble tras la intervención coronaria percutánea del tronco coronario izquierdo;Revista Española de Cardiología;2023-04

3. Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease;Revista Española de Cardiología (English Edition);2023-04

4. New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patients After Stenting for Left Main Coronary Artery Disease: Findings From a Prospective Observational Study;Circulation: Cardiovascular Interventions;2022-06

5. Follow-up of Left Main Patients Treated with PCI or CABG;Left Main Coronary Revascularization;2022